Unlock instant, AI-driven research and patent intelligence for your innovation.

Nanovesicles derived from bacteria of lactococcus genus and use thereof

A technology of lactococcus and vesicles, applied in streptococcus/lactococcus, bacteria used in food preparation, medical preparations containing active ingredients, etc.

Active Publication Date: 2020-12-04
MD HEALTHCARE INC
View PDF5 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, there have been no reports on diagnostic and therapeutic techniques using vesicles derived from bacteria of the genus Lactococcus

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Nanovesicles derived from bacteria of lactococcus genus and use thereof
  • Nanovesicles derived from bacteria of lactococcus genus and use thereof
  • Nanovesicles derived from bacteria of lactococcus genus and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0100] Example 1. Analysis of in vivo absorption, distribution and excretion patterns of bacteria and vesicles derived from bacteria

[0101] To assess whether gut bacteria and bacterial-derived vesicles are absorbed systemically through the gastrointestinal tract, the following experiments were performed. First, a dose of 50 μg of fluorescently labeled enterobacteria and enterobacteria-derived vesicles were each administered to the stomach of mice via the gastrointestinal tract, and fluorescence was measured after 0 min, 5 min, 3 h, 6 h, and 12 h. As a result of observing the whole image of the mouse, as Figure 1A As shown, bacteria were not taken up systemically, but vesicles derived from bacteria were absorbed systemically at 5 minutes after administration, and strong fluorescence was observed in the bladder at 3 hours after administration, making it possible to see that the vesicles were excreted. to the urinary tract. Furthermore, it can be seen that vesicles are pres...

Embodiment 2

[0103] Example 2. Metagenomic Analysis of Bacteria-Derived Vesicles in Clinical Samples

[0104] After first putting the clinical sample (such as blood, urine or saliva, etc.) test tube. After removing bacteria and impurities using a 0.22-μm filter, transfer them to a Centriprep tube (centrifugal filter 50kD) and centrifuge at 1,500×g and 4°C for 15 minutes, discard the material smaller than 50kD, and the residue Concentrate to 10ml. After bacteria and impurities were removed again using a 0.22-μm filter, supernatant was discarded and aggregated pellets were dissolved by performing ultracentrifugation at 150,000×g and 4°C for 3 hours using a 90Ti type rotor in normal saline (PBS).

[0105] Internal DNA was extracted from lipids by boiling 100 μl of vesicles isolated by the method described above at 100 °C, followed by cooling on ice for 5 min. Then, in order to remove the residual suspension, the DNA was centrifuged at 10,000×g and 4°C for 30 minutes, and only the supern...

Embodiment 3

[0109] Example 3. Metagenomic Composition of Bacteria and Bacteria-Derived Vesicles in Saliva of Diabetics and Normal Individuals analysis

[0110] After metagenomic analysis of saliva from 47 diabetic patients and 277 age- and sex-matched normal individuals by extracting genes from bacteria and vesicles present in saliva using the method of Example 2, milk Distribution of Bacillus and Lactococcus-derived vesicles. As a result, it was confirmed that bacteria of the genus Lactococcus and vesicles derived from bacteria of the genus Lactococcus were significantly reduced in the saliva of diabetic patients compared with the saliva of normal individuals (see Tables 2, 3 and figure 2 ).

[0111] _[Table 2]

[0112]

[0113] [table 3]

[0114]

[0115]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The present invention relates to vesicles derived from bacteria of the Lactococcus genus and a use thereof. The inventors thereof have experimentally confirmed that the vesicles are significantly reduced in samples obtained from patients with diabetes, myocardial infarction, atrial fibrillation, cerebral infarction, renal failure, Parkinson's disease and depression compared to healthy individuals,and that the vesicles inhibit the secretion of an inflammatory mediator due to pathogenic vesicles. Thus, the vesicles derived from bacteria of the Lactococcus genus according to the present invention may be useful for the purpose of developing a method for diagnosing diabetes, myocardial infarction, atrial fibrillation, cerebral infarction, renal failure, Parkinson's disease or depression, and acomposition for preventing or treating the diseases or an inflammatory disease.

Description

technical field [0001] The present invention relates to nanovesicles derived from bacteria of the genus Lactococcus and uses thereof, more particularly, to a method for diagnosing metabolic diseases, cardiovascular diseases, renal failure or Methods of neuropsychiatric diseases, and compositions for preventing or treating the above diseases or inflammatory diseases. Background technique [0002] Since the beginning of the 21st century, acute infectious diseases, which in the past were considered epidemics, have become less important, while chronic diseases with immune dysfunction due to the dissonance between humans and microbiomes have changed disease patterns, becoming Major diseases that determine quality of life and longevity in humans. In particular, metabolic diseases such as diabetes caused by Westernized eating habits, cardiovascular diseases such as myocardial infarction and stroke, neuropsychiatric diseases such as Parkinson's disease, dementia and depression, kid...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/689A61P25/18C12Q1/6851A23L33/135A61K35/747A61P3/10A61P9/10A61P25/00
CPCY02A50/30A23L33/135A61K35/747A61P3/10A61P9/10A61P25/00A61P25/18C12Q1/689C12Q1/6883A61K8/14A61K8/99A61K2800/413A61Q19/00C12Q1/6851A23V2002/00C12Q2531/113A23V2400/231A61K9/0073A61K35/744C12Q1/686G01N2800/2835G01N2800/2871G01N2800/304G01N2800/324G01N2800/326G01N2800/347
Inventor 金润根朴海心
Owner MD HEALTHCARE INC